Blog

  • Emotional Eaters Less Likely to Lose Weight on GLP-1 Drugs

    Emotional Eaters Less Likely to Lose Weight on GLP-1 Drugs

    Share on Pinterest
    Experts say emotional eating should be addressed before a person is prescribed a weight loss drug. Justin Paget/Getty Images
    • A new study reports that weight loss medications may not be as effective for people with emotional eating issues.
    • Weight loss drugs work by suppressing hunger, so they may not be as beneficial for those who overeat due to depression, boredom, or anxiety.
    • Experts say healthcare professionals should assess a person’s relationship to food before prescribing weight loss medication or recommending bariatric surgery.

    Weight loss drugs are not as effective when used by people with eating habits that are tied to emotions such as depression or anxiety.

    In their study, researchers reported that GLP-1 medications such as Ozempic were more effective for weight loss in people who tend to overeat because of the appearance and smell of food, compared to people who overeat due to emotional issues.

    The researchers said their findings suggest that healthcare professionals should assess a patient’s eating behavior patterns and treat those issues before prescribing weight loss medications.

    “GLP-1 receptor agonists are effective for individuals who experience weight gain or elevated blood glucose levels due to overeating triggered by external stimuli. However, their effectiveness is less expected in cases where emotional eating is the primary cause,” said Daisuke Yabe, MD, a professor of medicine at Kyoto University in Japan and a senior author of the study, in a statement.

    Experts not involved in the research agree that psychological issues should be addressed before a person is prescribed a weight loss drug or undergoes bariatric surgery.

    “It’s not just about overeating. We need to address underlying issues first,” said Mir Ali, MD, a general surgeon, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in California.

    “Everyone is different,” added Zhaoping Li, MD, a professor of clinical medicine at the University of California Los Angeles. “We need to learn who a patient is and what their reason is for overeating.”

    Kristin Kirkpatrick, a dietitian at the Cleveland Clinic Department of Wellness & Preventive Medicine and the president of KAK Consulting, said this latest research provide some valuable insights.

    “This was a small study but showed an interesting take away related to emotional eating and success in weight loss,” she told Healthline.

    “As a clinician with many patients on these drugs, the takeaway for me would be what education, support could potentially be given alongside the drug to help foster more mindful, intuitive eating patterns that may assist once the individual is off the drug.”

    For their study, the researchers monitored 92 people in Japan with type 2 diabetes who were beginning treatment with GLP-1 drugs.

    They tracked the participants’ progress at the beginning of their treatment, three months into the treatment, and 12 months after treatment began.

    They collected data on the study subjects’ body weight, body composition, diet, and relevant blood markers such as glucose and cholesterol levels.

    The scientists honed in on three different types of eating habits.

    • Emotional eating, where people eat in response to negative emotions.
    • External eating, where people eat because of the way food looks or smells.
    • Restrained eating, where people control their diet to lose weight.

    The researchers reported that the participants overall saw reductions in body weight, cholesterol levels, and body fat percentages during their year of treatment. Blood glucose levels also improved, but the changes were not statistically significant.

    However, the researchers said the results were more pronounced for people with external eating habits than for those with emotional or restrained eating patterns.

    They added that people with external eating issues had sustained changes in their eating habits while people with emotional or restrained eating patterns had returned to their baseline habits after one year.

    Li said people’s dietary patterns are a complicated matter. She said people can overeat due to boredom, stress, or anxiety.

    “Eating is a complex behavior,” she told Healthline. “People overeat for many reasons.”

    Ali noted that it can be difficult for a physician to diagnose emotional issues, so he suggested that those with potential eating issues be seen by a psychologist before any treatment is recommended.

    He pointed out that GLP-1 drugs work by reducing hunger impulses, but if a person is overeating for emotional reasons, then medications and surgery might not be the best place to start.

    “Suppressing hunger may ultimately not be that effective for some people,” he told Healthline.

    Li said it’s important for patients to know what they are up against.

    “We need to help people recognize the challenges,” she said. “We need to help people better understand the cues.”

    Kirkpatrick said she approaches eating patterns differently depending on a person’s particular issue.

    “Food can alter the way we feel, making us feel calm, or relaxed but many of the foods chosen when eating emotionally are not nutrient dense options, so the feeling, or benefit, is short term followed by a crash and a need to consume more of the food to feel calm again,” Kirkpatrick explained.

    “It can be a vicious cycle because the food never really heals and only provides a crutch that could lead to various other adverse outcomes due to a low nutrient-dense, high ultra-processed food dietary pattern.”

    For external eating issues, it’s more centered on the cues to which a person reacts.

    “I have patients that will get in their car to pick up emotional eating foods (think fast food, pizza, ice cream) so the cue is not necessarily in the house, but they are thinking about it, craving it,” Kirkpatrick said. “For others, it could be that they see, smell, or around a food and that is all it takes to consume it in excess. This is why dealing with the root causes of emotional eating is so important.”

    For restricted eating habits, it’s more about how food is viewed.

    “Part of a mindful, intuitive eating approach often means allowing foods into the diet every once in a while versus saying I can never have that food and then binging on it and feeling guilty afterward,” Kirkpatrick said.

    “I like to look at food as not good or bad, but choices that nourish our mind, body, and soul versus those that don’t. It’s not that we can never have the cookie or the fast-food item. Learning to include them every once in a while, still maintaining a nutrient-dense diet 80% of the time, may often be a better solution.”

    The Centers for Disease Control and Prevention (CDC) reports that 40% of U.S. adults are living with obesity.

    The percentage of obesity prevalence is about the same for males and females. People ages 40 to 59 have the highest percentage among age groups.

    Obesity is a chronic condition that usually results in an excess of body fat. It is generally diagnosed in males with a waist circumference of more than 40 inches and in females with a waist circumference of more than 35 inches. A body mass index (BMI) of 30 or greater is also common.

    Obesity can raise a person’s risk of developing a variety of health conditions. They include:

    There are a variety of medications that can be prescribed to help treat obesity.

    In recent years, weight loss drugs containing the active ingredient semaglutide, such as Ozempic and Wegovy, as and drugs containing the active ingredient tirzepatide, such as Zepbound and Mounjaro, have been used as treatments for obesity and type 2 diabetes.

    “Many of my patients say that the elimination of food noise is a game-changer when taking these medications – that the medication does in fact assist with emotional eating,” she explained.

    “However, their fear comes with the potential impact that could occur when and if they no longer take the medication and go back to the challenges they faced prior to starting the medication.”

    Continue Reading

  • All the Sound, Half the Price: Samsung’s Excellent Buds 3 Pro Are 50% Off – PCMag

    1. All the Sound, Half the Price: Samsung’s Excellent Buds 3 Pro Are 50% Off  PCMag
    2. Galaxy Buds 3 FE Review: Samsung’s ‘Fan Edition” Wireless Earbuds Are Just Enough  Gizmodo
    3. Samsung Galaxy Buds3 FE launched with real-time translation at Rs 12,999  Times of India
    4. Samsung Galaxy Buds 3 FE Launched in India With ANC, Galaxy AI Features: Price, Specifications  Gadgets 360
    5. Samsung’s underrated Galaxy Buds 3 with 2-year warranty are a whopping 58% off right now  Notebookcheck

    Continue Reading

  • Best SteelSeries Tech Sale: Where to Shop

    Best SteelSeries Tech Sale: Where to Shop

    All products and services featured are independently chosen by editors. However, Billboard may receive a commission on orders placed through its retail links, and the retailer may receive certain auditable data for accounting purposes.

    Looking to upgrade your gaming setup without breaking the bank? Well, you’ve come to the right place.

    If there’s one thing that the team at ShopBillboard loves, it’s a deal, especially on the latest tech. Right now, Amazon is running a major sale on SteelSeries products such as headsets, keyboards and more. We’re talking up to 42% off on products that will make your PC and console gaming experience so much smoother. We’ve picked out a few of our favorite sale tech from SteelSeries that you can shop right now at Amazon, helping you narrow down your search for the best gaming setup possible.

    SteelSeries New Arctis Nova 3 Multi-Platform Gaming Headset

    A black headset that is compatible with many consoles.

    Best SteelSeries Tech Sale: Where to Shop

    SteelSeries Arctis Nova Pro Wired Gaming Headset

    A black wired headset.

    SteelSeries features a bunch of headsets, some wired, some wireless, that are compatible with a slew of consoles. We personally like the Arctis Nova Pro for $179.99, the New Arctis Nova 3 for $79.99 and the Arctis Nova Pro Wireless for $299.99.

    Explore

    See latest videos, charts and news

    The New Arctis Nova 3 is currently 20% off and is a great beginner headset, and one of the most affordable options of the bunch. It is compatible with PC, PS5/PS4, Xbox Series X|S and the Nintendo Switch. The headset sits over the ears and features the best-in-class audio for gaming with High Fidelity Drivers that reproduce sound with quality accuracy. The resulting sound is immersive, making you feel like you’ve stepped into your game.

    If your audio is not to your liking, it is fully customizable thanks to first-in gaming Pro-grade Parametric EQ, giving users the power to adjust frequency, bandwith and gain to their liking. The attached mic is noise-canceling powered by AI. While the tech on the New Arctis Nova 3 is impressive, its comfort level is even more so. These headphones are equipped with rotating earcups and AirWeave Memory Foam cushions that sit gently atop the ears, allowing you to game for hours on end without discomfort. It also changes colors.

    Best SteelSeries Tech Sale: Where to Shop

    SteelSeries Arctis Nova Pro Wireless Headset

    White wireless headset.

    The Arctis Nova Pro is another affordable option that is currently 28% off. It is wired and compatible with Xbox X|S, Xbox One, PC, PS4|5 and Nintendo Switch. Like our last entry, the sound on these headphones is immersive thanks to those aforementioned High Fidelity Drivers. You can also tailor your audio experience with that Pro-grade Parametric EQ. Unlike our last entry, these headphones can plug into two systems at once and seamlessly switch between the two with the press of a button.The attached mic is noise-canceling, with help from AI, and the fit of the headset is adjustable for extra comfort while deep in an intense gaming session.

    Finally, we’ve got the Arctis Nova Pro, a wireless headset for our serious gamers. The headset is currently 21% off and is compatible with Xbox, PC, PS5, PS4, Switch and Mobile. Like our other picks, this tech is noise-canceling. Unlike our last picks, this headset has two hot-swappable batteries for endless hours of gaming and neodymium magnetic drivers that allow for more efficient and more accurate audio. You know it’s good because it’s been worn by professional gaming legends such as Rain and Faker.

    Best SteelSeries Tech Sale: Where to Shop

    SteelSeries Apex 3 TKL RGB Gaming Keyboard

    A rainbow gaming keyboard.

    Best SteelSeries Tech Sale: Where to Shop

    SteelSeries Aerox 5 Wireless – Holey RGB Gaming Mouse

    A lightweight gaming mouse.

    For PC-specific gaming, we’ve included Apex 3 TKL RGB Gaming Keyboard for $92.99 and Aerox 5 Wireless – Holey RGB Gaming Mouse for $98.50. Apex 3 TKL RGB Gaming Keyboard is another great starter keyboard for new PC gamers. The keyboard is made out of durable but lightweight aluminum alloy and is impressively responsive. RGB illumination gives the keyboard a dynamic look that reacts and changes based on your actions. It also has an OLED smart display, allowing users to customize with gifs, game info and Discord messages.

    We’d pair this keyboard with the Aerox 5 Wireless – Holey RGB Gaming Mouse. The tech is lightweight, water-resistant and comes with nine fully customizable buttons, allowing you to tailor your gaming experience to your specific needs. Additionally, the mouse has a whopping 180-hour battery life. If all that hasn’t sold you, the mouse changes colors like the keyboard.

    Continue Reading

  • Egyptian study maps dengue-carrying mosquito in El-Quseir, urges focused action in urban hotspots

    Egyptian study maps dengue-carrying mosquito in El-Quseir, urges focused action in urban hotspots

    A new Egyptian study has mapped the spread and breeding grounds of Aedes aegypti—the mosquito responsible for transmitting dengue fever—in the Red Sea city of El-Quseir, raising concern for urban areas most at risk. Published in The Egyptian Journal of Remote Sensing and Space Sciences, the study combines satellite data with field surveys to guide more targeted and cost-effective mosquito control efforts.

    The research team used Landsat-8 satellite imagery from May to June 2023, the peak breeding season for Aedes aegypti, to analyze environmental factors that influence mosquito populations. These included land surface temperature, vegetation cover, vegetation moisture, surface water presence, drainage networks, and urban development. This data was integrated into a GIS-based model to generate detailed risk maps of the city.

    To validate the remote sensing findings, field teams surveyed 912 homes across five neighborhoods in El-Quseir, collecting data on mosquito larvae and breeding sites using internationally recognized indicators such as the House Index, Container Index, and Breteau Index. The field data closely aligned with the satellite-generated risk zones, confirming the model’s accuracy.

    Mona Younes, the study’s corresponding author and Head of the Agricultural Applications Department at Egypt’s National Authority for Remote Sensing and Space Sciences, explained that the optimal temperature range for Aedes aegypti to complete its life cycle is between 10°C and 40°C. Activity drops off below 10°C, while survival declines above 40°C. Although El-Quseir’s coastal humidity does not alter this temperature window, it improves egg and larval survival within it. She noted that during extreme heat or cold, eggs may enter dormancy and hatch when conditions become favorable again.

    Urban areas were found to be particularly vulnerable, with 91% of El-Quseir’s built-up land—approximately 9.11 km² of 10 km²—located within high-risk zones. The most exposed neighborhoods include South El-Quseir, North Awina, and the area around Al-Hamrawi. The study also identified a seasonal pattern in mosquito activity, with a major peak in December and January and a secondary bump in spring or early summer, depending on the neighborhood. In contrast, mosquito larvae were nearly absent in August and September, when temperatures exceeded 40°C and hindered development.

    Younes warned that in winter, the Breteau Index surpassed 20 in some areas, a level that signals increased risk of dengue transmission and calls for immediate intervention. She stressed that mosquito control efforts must be evidence-based and seasonally timed. Rather than city-wide campaigns, teams should be dispatched to identified hotspots. Control activities should focus on preparing before the summer heat by removing breeding sites and treating water storage areas, intensifying field efforts during the summer, and following up in winter, especially in warm and humid indoor environments where mosquito activity can persist.

    While the study’s approach involves upfront costs—such as satellite imagery, GIS software, and training—Younes emphasized that the long-term savings and improved outcomes outweigh the initial investment. By directing resources precisely where they are needed, cities can avoid the inefficiency of broad, unfocused control measures. However, she acknowledged key challenges, including a lack of trained personnel, limited digital infrastructure, and slow coordination between agencies. To address these, her team has simplified map outputs for local use, trained municipal staff, and built partnerships with the health and environment ministries.

    The study underscores the urgent need for cities to adopt smarter, more data-driven strategies to combat dengue. As climate change and urbanization continue to reshape the landscape of disease transmission, Younes and her team offer a replicable model for using technology and science to protect public health.

    Continue Reading

  • 6 in 10 US adults eligible for pneumococcal vaccine don’t receive it, survey suggests

    6 in 10 US adults eligible for pneumococcal vaccine don’t receive it, survey suggests

    Less than 40% of a sample of US adults eligible for the pneumococcal vaccine had received the vaccine by January 2024, a Centers for Disease Control and Prevention (CDC)–led survey shows.

    The researchers, who published the findings this week in Vaccine, surveyed 1,553 vaccine-eligible adults aged 19 to 64 years about their knowledge, attitudes, and pneumococcal vaccine status in January 2024. Adults aged 65 years and older and those aged 19 to 64 years with conditions such as diabetes and cancer are eligible for the vaccine.

    Updated vaccine recommendations 

    “Pneumococcal disease contributes to significant morbidity in the United States,” the authors wrote. “Before October 2024, the Advisory Committee on Immunization Practices [ACIP] recommended pneumococcal vaccination for risk-eligible adults aged 19–64 years; however, as of 2023, vaccination coverage remained low (33.1%).”

    In October 2024, ACIP recommended expanding the age-based recommendation to those aged 50 years or older, from 65 years and up, to improve vaccine uptake among high-risk adults.

    “Some of the factors that prompted the ACIP to make this change included suboptimal pneumococcal vaccination coverage among risk-eligible adults, preventable differences in pneumococcal disease incidence most notable among adults aged 50–64 years, and the relatively large proportion (30–50 %) of risk-eligible adults aged 50–64 years,” the researchers noted.

    Less familiarity with vaccine 

    Among survey respondents, 39.2% said they had received at least one dose of pneumococcal vaccine, 50.6% were unvaccinated, and 10.2% were unsure whether they’d been vaccinated.

    Relative to vaccinated respondents, a larger proportion of unvaccinated participants were aged 35 to 49 years (37.1% vs 30.1%) and had a high school education or less (52.2% vs 43.3% with a high-school education or less; 34.9% vs 37.6% with a college degree; and 12.9% vs 19.1% with a master’s or professional degree). 

    A smaller percentage of unvaccinated participants had a healthcare visit in the previous year (69.2% vs 79.4%) or health insurance (86.8% vs 91.7%). Compared with vaccinated adults, unvaccinated respondents of all age-groups were less familiar with pneumococcal vaccines, perceived that the likelihood of infection and severe disease were lower, and were less amenable to be vaccinated after receiving a recommendation from their clinician.

    The findings were statistically significant across all age-groups, except for perceived likelihood of pneumococcal infection in adults aged 50 to 64 years and anticipated disease severity in those aged 35 to 49.

    Clinician lack of familiarity may be barrier 

    Participants with health insurance and those with more years of education were more likely to be vaccinated after receiving a clinician recommendation. The most common reasons for getting vaccinated were, “To protect myself from getting pneumococcal disease” (62.7%) and “My healthcare provider recommended that I get vaccinated” (57.9%). The top reasons for being unvaccinated were, “I did not know I needed to get a pneumococcal vaccine” (31.7%) and “My healthcare provider never recommended I should get a pneumococcal vaccine” (27.9%). 

    While many healthcare providers recognize the importance of pneumococcal vaccination, their unfamiliarity with the nuances of the risk-based vaccination recommendations may impede their accurate interpretation and implementation.

    Clinicians (63.6%) were cited as the most trusted source of information, followed by the CDC (42.5%), regardless of participant vaccination status.

    “While many healthcare providers recognize the importance of pneumococcal vaccination, their unfamiliarity with the nuances of the risk-based vaccination recommendations may impede their accurate interpretation and implementation,” the authors wrote.These challenges could contribute to the observed differences in pneumococcal disease incidence across demographic groups.” 

    Provider resources available 

    The team recommended continued efforts to improve clinician and patient education by using existing resources: To increase vaccination coverage among all adults with indications, the National Vaccine Advisory Committee developed Standards for Adult Immunization Practice, which includes recommendations for all providers to assess immunization needs at each patient encounter; to recommend needed vaccines to patients; and to stay up to date on and educate patients about vaccine recommendations.” 

    Clinicians can use CDC’s free PneumoRecs VaxAdvisor app for current patient-specific recommendations. “For adults aged 50–64 years, transitioning from a risk-based to an age-based vaccination approach following the updated ACIP recommendation may improve pneumococcal vaccination coverage by removing implementation barriers associated with a risk-based recommendation for providers,” the researchers concluded.

    Continue Reading

  • Music body ICMP laments “wilful” theft of artists’ work

    Music body ICMP laments “wilful” theft of artists’ work

    A major music industry group, ICMP, has lamented the use of artists’ work by AI companies, calling them guilty of “wilful” copyright infringement, as the battle between the tech firms and the arts industry continues.

    The Brussels-based group known as the International Confederation of Music Publishers (ICMP) comprises major record labels and other music industry professionals. Their voice adds to many others within the arts industry that have expressed displeasure at AI firms for using their creative work to train their systems without permission.

    ICMP accuses AI firms of deliberate copyright infringement

    ICMP director general John Phelan told AFP that big tech firms and AI-specific companies were involved in what he termed “the largest copyright infringement exercise that has been seen.” He cited the likes of OpenAI, Suno, Udio, and Mistral as some of the culprits.

    The ICMP carried out an investigation for nearly two years to ascertain how generative AI firms were using material by creatives to enrich themselves.

    The Brussels-based group is one of a number of industry bodies that span across news media and publishing to target the fast-growing AI sector over its use of content without paying any royalties.

    Suno and Udio, who are AI music generators, can produce tracks with voices, melodies, and musical styles that echo those of the original artists such as the Beatles, Depeche Mode, Mariah Carey, and the Beach boys.

    “What is legal or illegal is how the technologies are used. That means the corporate decisions made by the chief executives of companies matter immensely and should comply with the law,” Phelan told AFP.

    “What we see is they are engaged in wilful, commercial-scale copyright infringement.”

    Phelan.

    In June last year, a US trade group, the Recording Industry Association of America, filed a lawsuit against Suno and Udio. However, an exception is Eleven Music, another AI-generated music service provider, which, according to Phelan, signed a deal with the Kobalt record label in August.

    According to AFP, tech firms normally invoke “fair use,” which is a copyright exception that allows the use of creative works without permission under certain circumstances. Tech firms OpenAI, Google, Mistral, Suno, and Udio did not comment on the matter.

    Research done by the ICMP revealed that AI firms had done widespread “scraping,” which is a practice that uses programs that are known as “crawlers” that explore the internet for content. The research was first published in music outlet Billboard earlier this month.

    With these programs, AI firms can harvest lyrics for their models, which then utilize them to recreate them without permission from the original artist, according to the ICMP.

    Artists want enhanced transparency

    To ensure there is transparency, rights holders want tougher regulation, which can be achieved through the European Union’s Artificial Intelligence Act.

    “It is essential to understand the scale of the threat facing authors, composers and publishers,” warned Juliette Metz, president of the French music publishers’ association and also an ICMP member.

    “There can be no use of copyright-protected music without a licence.”

    Metz.

    The battle between AI firms and the arts industry has intensified as the AI industry continues to grow. In the US, Anthropic agreed to pay at least $1.5 billion into a compensation fund for authors, rights holders, and publishers after they sued the AI startup for illegally downloading millions of books to train its systems.

    Universal, Warner, and Sony, US-based music majors, are negotiating with Suno and Udio with the hope of striking a licensing deal. This comes as AI-generated music is already finding its way into streaming platforms.

    According to AFP, AI-generated music accounts for 28% of music that is uploaded on the French music platform known as Deezer, and it has reportedly ballooned over the past year in uploads.

    A study carried out by the International Confederation of Societies of Authors and Composers (CISAC) an industry body that represents more than five million creators worldwide, warned about the adverse impacts of AI-generated music. It argues that artists’ income may shrink by as much as 20% in the next four years due to growing AI-made music.

    In the UK, top artists have also expressed concerns about the growing use of their work by AI firms. They have called on the government to protect their work from AI exploitation. This came after the government indicated plans to permit AI developers to train systems on books, lyrics, scripts, and music without prior permission, which were condemned by artists. Top British musician Elton John said such a policy leaves the door wide open for an artist’s life’s work to be stolen.

    Want your project in front of crypto’s top minds? Feature it in our next industry report, where data meets impact.

    Continue Reading

  • Oil prices ease on US demand concerns – Reuters

    1. Oil prices ease on US demand concerns  Reuters
    2. Dollar Strength and Energy Demand Concerns Weigh on Crude Prices  Yahoo Finance
    3. Oil Futures Snap Three-Session Winning Streak  The Wall Street Journal
    4. Oil Holds Decline as Fed Rate Cut, Weak US Labor Market Assessed  Bloomberg.com
    5. WTI drifts lower to near $63.50 amid US demand concerns  FXStreet

    Continue Reading

  • Prenatal Opioid Pain Medications Likely Not Linked to Autism or ADHD Risk

    Prenatal Opioid Pain Medications Likely Not Linked to Autism or ADHD Risk

    A recent study suggests that confounding may explain the increased risks of autism spectrum disorder (ASD) and ADHD associated with prenatal prescribed opioid analgesic (POA) exposure.1

    Many obstetrician-gynecologists prescribe opioid analgesics to help manage their patients’ pregnancy pain. However, research has suggested a potential link between prenatal POA exposure and neurodevelopmental disorders.

    It was not known if the association between prenatal POA exposure and neurodevelopmental disorders in children is causal or driven by confounding. In this retrospective study, investigators analyzed how the dose and duration of POA use during pregnancy were associated with autism and ADHD risk in children.

    “We wanted to conduct this study to help provide more information for pregnant individuals and their physicians who are trying to make complex decisions about how to best manage pain during pregnancy,” said lead investigator Emma N. Clearly, BA, from Indiana University Bloomington, and colleagues, in a statement.2 “While this study is not able to rule out small increased risks with high amounts of exposure, the results suggest that there is not a causal effect of prescribed opioid analgesics on risk for two common neurodevelopmental disorders, providing more data to support decision-making.”

    Using national register data from Sweden, this study examined a population-based cohort, with nearly half female (48.6%).1 The ASD cohort included 1,267,978 children born between July 1, 2007, and December 31, 2018, with a follow-up through 2021. Since ADHD is typically diagnosed later, investigators applied a shorter eligibility window, including 918,771 children born through December 31, 2015.

    The team used test-mining algorithms to calculate cumulative dose and duration of POA exposure during pregnancy from filled prescriptions and to identify those prescribed on an “as needed” basis.1 Outcomes included inpatient or outpatient clinical diagnoses of ASD and ADHD or dispensed ADHD medications.

    To address unmeasured confounding, the analysis incorporated several comparison groups: children whose birthing parent had a diagnosed painful condition but did not receive POAs, children whose birthing parent received POAs in the year prior to but not during pregnancy, and unexposed siblings.

    Among the 1,267,978 children, 4.4% were exposed to POAs when in their mother’s womb. At 10 years old, the cumulative incidence of ASD was 3.6% and 2.9% among children exposed to high and low POA doses, respectively, compared with 2% among children unexposed to POAs.1

    Unadjusted models (hazard ratio [HR], 1.74; 95% confidence interval [CI], 1.63–1.87) and models adjusted for measured covariates (HR, 1.34; 95% CI, 1.24–1.44) showed that the cumulative maximum POA dose was associated with an increased risk of ASD. However, these associations were weak or nonexistent in alternative study designs, particularly when compared with children whose birthing parent had received POAs before, but not during, pregnancy (HR, 1.10; 95% CI, 1.00 – 1.21). The sibling comparison analysis showed no associations between ASD and POA exposure (HR, 0.99; 95% CI, 0.81 – 1.21).1

    Investigators noted that they did not assess the impact of extremely high doses and long durations of opioids due to limited data in the Swedish cohort.2

    “We are excited to share our findings because we believe that they have important clinical implications,” said investigator Ayesha C. Sujan, PhD, from Stanford University School of Medicine, in the statement.2 “Our findings suggest that the observed associations between prenatal exposure to opioid analgesics and two major neurodevelopmental disorders—autism and ADHD—are largely driven by factors leading up to opioid analgesic use rather than the opioid exposure itself. Our results, therefore, elucidate the critical need to provide pregnant individuals experiencing pain with psychosocial support and evidence-based pain management tools. These can include both pharmaceutical and non-pharmaceutical approaches.”

    References

    1. Cleary EN, Sujan AC, Rickert ME, et al. Prescribed opioid analgesic use in pregnancy and risk of neurodevelopmental disorders in children: A retrospective study in Sweden. PLoS Med. 2025;22(9):e1004721. Published 2025 Sep 16. doi:10.1371/journal.pmed.1004721
    2. Prescribed opioid pain medications during pregnancy likely aren’t associated with increased risk of autism, ADHD. EurekAlert! Published September 16, 2025. Accessed September 17, 2025. https://www.eurekalert.org/news-releases/1097557

    Continue Reading

  • Netflix’s Ted Sarandos’ Career Advice for Young Professionals

    Netflix’s Ted Sarandos’ Career Advice for Young Professionals

    • Netflix co-CEO Ted Sarandos advised young professionals to be dependable in their roles.
    • He said the trait is becoming a “lost art” and there’s an “entitlement” among younger generations.
    • Sarandos started off as a video store clerk and rose to co-CEO of Netflix.

    Ted Sarandos has a message for the younger generation: Show up.

    The Netflix co-CEO shared one of the most important career lessons he’s passed on to his own children, in an episode of Skims boss Emma Grede’s “Aspire” podcast that aired Tuesday. Sarandos said the advice could be applied to many young adults hoping to level up in their field.

    “The most important thing in any job, in any role, is that you can be depended on,” Sarandos said when asked what advice he gives his two children who work in the entertainment industry.

    It sounds simple enough, but Sarandos said it’s becoming a “lost art” among the younger generation of professionals who’ve built up a sense of “entitlement.” Those who people can count on to show up when they’re supposed to, he said, will go far in their careers.

    “It’ll get you into rooms that you probably wouldn’t have gotten into before,” Sarandos told Grede.

    Representatives for Netflix didn’t immediately respond to a request for comment from Business Insider.

    Sarandos has firsthand knowledge about grinding from the bottom of an industry to the top. He got his start as a video store clerk renting out DVDs in Arizona. Years later, he met Netflix cofounder Reed Hastings and is now at the helm of the company alongside co-CEO Greg Peters.

    During his time running the video store, Sarandos said he treated it like a business school course and film school wrapped up into one. He learned what went into customers’ movie choices, studied films, and carried out business duties as well.

    He made the most of the experience, and it seems to have paid off.

    “You owe it to the world to show up,” Sarandos said.


    Continue Reading

  • Breaking the Code review – tribute to Alan Turing given a fascinating update | Theatre

    Breaking the Code review – tribute to Alan Turing given a fascinating update | Theatre

    When premiered in 1986, giving Derek Jacobi a key career role, Hugh Whitemore’s Breaking the Code was instrumental in spreading knowledge of the precocious brilliance of mathematician Alan Turing, whose brutal treatment by a homophobic and ungrateful state contributed to his suicide in 1954 aged 41.

    Though drawing on Andrew Hodges’ 1983 biography, Alan Turing: The Enigma, Whitemore was ahead of several later plays and movies, including Benedict Cumberbatch in The Imitation Game (2014). So, for a long time, Whitemore and Jacobi’s portrayal of Turing formed his public image, which was inevitably tragic, given that he remained a convicted criminal for loving men and his theories had not yet been fully realised.

    Joe Usher, behind, and Mark Edel-Hunt in Breaking the Code. Photograph: Manuel Harlan

    But Turing is now officially pardoned and features on a British banknote in a world that owes much to him for the evolutions in digital technology and now AI (in which Turing saw both the gains and dangers). So Jesse Jones’ smart revival offers a more redemptive portrait of a true genius who lived in an age that proved fatal to him.

    Starting in a Northampton theatre 23 miles from Bletchley Park, where Turing saved British shipping by cracking German naval codes, this touring production will end in Manchester, where he died. It adds a new epilogue by Neil Bartlett, set in the present day at Sherborne School, Turing’s alma mater. The punchy, touching speech follows Ian McEwan’s 2019 novel Machines Like Me in finding a way to give Turing some degree of posthumous triumph over his destruction.

    Most important to this Turing 2.0, though, is a superb performance by Mark Edel-Hunt. It is tempting to play Turing as if he always knew he was in a tragedy but, shown extracts out of context, an audience might think this were a comedy. Edel-Hunt also delivers long speeches of mathematical and computing exposition with immaculate clarity, exuberantly suggesting the humour and sensuality that Turing found in numbers and nature, his body and tongue tangibly loosening when his great brain engages.

    Acting of matching quality comes from Peter Hamilton Dyer as Dillwyn Knox, the cryptographer who recruited Turing to Bletchley; the men’s enthralling dialogues about reality and pretence are, as often in Whitemore’s writing, only fully understood in retrospect through later data. Carla Harrison-Hodge as Pat Green, a Bletchley colleague on whom Turing’s mother hopes he is sweet, radiates braininess and the pain caused to her by the play’s sub-theme of humans being harder to read than machines. Joe Usher, as two of Turing’s love interests, is especially impressive in a brilliant scene in Greece where a language barrier allows Turing to spill his secrets without truly doing so. Joseph Edwards does a nice double as a Sherborne student in the 1920s and 2020s. This is not just a revival but a fascinating reboot.

    At Royal & Derngate, Northampton, until 27 September. Then touring

    Continue Reading